Welcome to our dedicated page for AHCCF news (Ticker: AHCCF), a resource for investors and traders seeking the latest updates and insights on AHCCF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AHCCF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AHCCF's position in the market.
Apollo Healthcare Corp. has completed its plan of arrangement with Anjac SAS, under which Anjac has acquired all of Apollo's issued Class B shares for $4.50 each in cash. Shareholders approved the arrangement on December 24, 2021, and the Ontario Superior Court endorsed it on January 4, 2021. Following the completion, Apollo shares will be delisted from the Toronto Stock Exchange and OTCQX, with the company applying to cease being a reporting issuer. This partnership aims to enhance product innovation in personal care and OTC technologies.
Apollo Healthcare Corp. announced that the Ontario Superior Court of Justice has approved its statutory plan of arrangement, allowing Anjac SAS to acquire all issued Class B shares for approximately $229 million. Shareholders will receive $4.50 per share in cash. The transaction is expected to close on January 7, 2022, contingent upon customary conditions. Following the completion, Apollo Shares will be delisted from the Toronto Stock Exchange and OTCXQ Marketplace, and the company will cease to be a reporting issuer.
Apollo Healthcare Corp. (TSX: AHC, OTC QX: AHCCF) reported its financial results for Q3 ended September 30, 2021. The Company generated revenues of $31.5 million for the quarter and $115.4 million for the nine-month period with an EBITDA of $5 million and $31.8 million, respectively. Apollo remains debt-free with $35.2 million in cash and a $50 million revolving credit facility. Notably, the Company announced an acquisition agreement with Anjac SAS on November 5, 2021. Detailed financial statements are available on SEDAR.
Apollo Healthcare Corp. (AHCCF) reported second quarter financials for 2021, showcasing revenues of $33.9 million and EBITDA of $10 million. The Company's total revenues for the first half reached $97.8 million, with an adjusted EBITDA of $27.8 million. Apollo remains debt-free with cash reserves of $39.5 million and has access to a $50 million credit facility. The Board has approved plans to repurchase up to 3.6 million shares, reinforcing commitment to shareholder value. The firm aims to enhance its global footprint via strategic acquisitions and operational efficiencies.
Apollo Healthcare Corp. (TSX: AHC, OTC QX: AHCCF) reported Q1 2021 revenues of $51.1 million, up 10% year-over-year but down 40% from Q4 due to COVID-19 market impacts. EBITDA increased to $16.8 million from $8.4 million in Q1 2020, and adjusted EBITDA rose to $17.5 million from $5.5 million. Cash flow from operations improved significantly to $14.8 million from $4.7 million, with $45.1 million cash on hand and access to a $50 million credit line. The company repurchased 23,528 shares in Q1 under its buyback program.
Apollo Healthcare Corp. (TSX: AHC, OTC QX: AHCCF) has announced financial results for Q4 and the year ended December 31, 2020. Q4 revenues reached $87.2 million, marking a significant increase from $41.8 million in Q4 2019. Year-to-date revenues totaled $321.7 million, up from $167.1 million in 2019. EBITDA for Q4 was $25.2 million, compared to a loss of $1.7 million in 2019. The company has eliminated all debt and has access to a $50 million liquidity facility. Further detailed results are available in the MD&A filed on SEDAR.
OTC Markets Group Inc. announced that Apollo Healthcare Corp. has qualified to trade on the OTCQX Best Market, upgrading from the Pink market on March 3, 2021. This upgrade enables Apollo Healthcare Corp. to provide transparent trading for U.S. investors. The company is recognized as the largest Private Label and Control Label Personal Care Manufacturer in Canada, listed under the symbol AHCCF. The move reflects strict compliance with financial standards and corporate governance. U.S. investors can now access real-time financial data for the company.
